Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
NCT07428954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2026-02-24
Summary
This study aims to determine if an artificial intelligence (AI) medical device can help doctors more accurately identify a wide variety of skin conditions and improve the efficiency of patient consultations. While many patients visit primary care for skin issues, general doctors may sometimes have different opinions from specialists, which can lead to delays in getting the right treatment.
The researchers hypothesized that using the AI tool would increase the true diagnostic accuracy of healthcare professionals for multiple skin conditions. To test this, 16 doctors (including 10 general practitioners and 6 dermatologists) evaluated 29 different medical images.
For each case, the doctors followed a structured process:
* Initial Assessment: Doctors first gave a diagnosis based only on the patient's image and medical history.
* AI Support: Doctors were then shown the AI's top five suggested diagnoses and confidence levels to see if they wished to adjust their final decision.
* Clinical Utility: Doctors also indicated if the patient required a specialist referral and if the case could be handled through a remote (online) consultation.
The primary question the study tried to answer was whether AI support could significantly improve correct diagnoses across 13 different types of skin pathologies-ranging from common rashes to skin cancer-while also making the consultation process faster and more effective for both doctors and patients.
Conditions
Interventions
- DEVICE
-
AI-based medical device for aided diagnosis in Dermatology
The intervention consists of a Computer-Aided Diagnosis (CAD) software-only medical device that utilizes computer vision algorithms to analyze digital images of skin structures. During the study, healthcare professionals use the tool as a diagnostic support system to assist in the evaluation of complex dermatological conditions.
Sponsors & Collaborators
-
AI Labs Group S.L
lead INDUSTRY
Principal Investigators
-
Antonio Martorell, PhD · Hospital Universitari de Manises
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2024-10-10
- Completion
- 2024-10-10
Countries
- Spain
Study Locations
More Related Trials
-
Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris
NCT06032078 ·Status: UNKNOWN ·Phase: NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
NCT05942248 ·Status: RECRUITING ·Phase: NA
-
Actinic Keratoses Treatment With Metvix® in Combination With Light
NCT02373371 ·Status: COMPLETED ·Phase: PHASE3
-
The Influence of an E-learning Program on Recognition of Actinic Keratosis
NCT05987553 ·Status: ACTIVE_NOT_RECRUITING
-
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
NCT02759900 ·Status: UNKNOWN ·Phase: NA
-
Expert Consensus on the Clinical Management of Melasma: A Delphi Method Study
NCT07296549 ·Status: ENROLLING_BY_INVITATION
-
Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum
NCT06869291 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
NCT00615355 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head
NCT00204542 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions
NCT04493021 ·Status: COMPLETED ·Phase: NA
-
CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPICAL FORMULA ON DEPIGMENTATION OF LENTIGO SPOTS
NCT07239726 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
NCT04842422 ·Status: COMPLETED ·Phase: PHASE4
-
Advanced Harmonic Generation Microscopy for Treatment Assessment of Cutaneous Pigmentary Disorder
NCT03578315 ·Status: COMPLETED ·Phase: NA
-
Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis
NCT00987246 ·Status: COMPLETED ·Phase: PHASE3
-
UVA1 Light for Treatment of Scleroderma and Similar Conditions
NCT00476801 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne
NCT01591304 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin
NCT02660320 ·Status: COMPLETED ·Phase: NA
-
Dermatosis Papulosa Nigra
NCT00710203 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis
NCT02085395 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Decision Aid for the Treatment of Actinic Keratosis
NCT06008171 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment
NCT04640207 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients
NCT05467839 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
NCT00294320 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
NCT02150863 ·Status: TERMINATED ·Phase: NA
-
Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris
NCT07078461 ·Status: RECRUITING ·Phase: NA